Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02923531
Title Addition of X4P-001 to Nivolumab Treatment in Patients With Renal Cell Carcinoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors X4 Pharmaceuticals
Indications

renal cell carcinoma

Therapies

Nivolumab + X4P-001

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.